Table 1 |
|||||||||
|
Spectrum of PIK3CA mutations in gastric adenocarcinoma |
|||||||||
|
Case |
Nucleotide Substitutiona |
Amino acid change |
Age |
Sex |
MSI Statusb,c |
KRAS Mutationc |
Tumour site |
Tumour type |
IMd |
|
|
|||||||||
|
28 |
A3140G |
H1047R |
37 |
M |
Stable |
- |
Body |
Intestinal |
0 |
|
100 |
G1633A |
E545K |
79 |
F |
High |
- |
Antrum |
Intestinal |
1 |
|
240 |
G1624A |
E542K |
74 |
M |
High |
G12D |
Antrum |
Intestinal |
1 |
|
310 |
A3140G |
H1047R |
72 |
F |
High |
G13D |
Antrum |
Intestinal |
1 |
|
|
|||||||||
|
aNucleotide change at the position within coding sequence, where position 1 corresponds to the first position of the start codon bHigh, high level of MSI; Stable, microsatellite stable cAnalysis of KRAS mutations have been performed and reported previously [16] dIM, the presence of intestinal metaplasia at tumour edge; 1, present; 0, absent |
|||||||||
|
Li et al. BMC Cancer 2005 5:29 doi:10.1186/1471-2407-5-29 |
|||||||||